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E6Cancer-associated epithelial to mesenchymal transition (EMT) is crucial for invasion and metastasis.
Molecular hallmarks of EMT include down-regulation of the epithelial adhesion protein E-cadherin and de-
novo expression of N-cadherin and the mesenchymal intermediate ﬁlament proteins vimentin and
ﬁbronectin. Expression of HPV16 E7 in normal human epithelial cells caused increased levels of vimentin
and ﬁbronectin, whereas the epithelial adhesion protein E-cadherin was expressed at decreased levels.
Similar expression patterns of vimentin, ﬁbronectin and E-cadherin were also detected in cells expressing
HPV16 E6 and E7 or the entire HPV16 early transcriptional unit. HPV16 E6 and E7 were each able to induce N-
cadherin expression. Interestingly, these changes in expression levels of EMT-associated proteins are not
similarly reﬂected at the level of mRNA expression, suggesting that HPV16 oncoproteins also modulate EMT
through non-transcriptional mechanisms. Hence, HPV16 oncoproteins may contribute to malignant
progression through EMT induction.
© 2009 Elsevier Inc. All rights reserved.Introduction
Human papillomaviruses (HPVs) are small DNA viruses that infect
basal epithelial cells and cause hyperproliferative lesions. Of the ∼140
described HPV genotypes approximately 40 are associated with
infections of mucosal epithelia and are further classiﬁed into high-
and low-risk groups based on the relative malignant potential of the
lesions that they cause. Whereas low-risk HPVs, such as HPV6 and 11,
cause benign genital warts, high-risk HPVs, such as HPV16 and HPV18,
cause premalignant squamous intraepithelial neoplasias that can
progress to cervical carcinomas (reviewed in zur Hausen, 2002).
Integration of high-risk HPV genomes into a host cell chromosome is a
frequent hallmark of malignant progression and leads to persistent,
deregulated expression of the E6 and E7 oncoproteins, which is
necessary and sufﬁcient for induction and maintenance of the
transformed phenotype (reviewed in Munger et al., 2004). High-risk
HPV E6 and E7 oncoproteins have neither enzymatic nor speciﬁc DNA
binding activities, and function by perturbing host cellular regulatory
networks. High-risk HPV E7 proteins bind and induce the degradation
of the hypophosphorylated, growth suppressive form of the retino-
blastoma tumor suppressor protein (pRB) (Boyer et al., 1996; Dyson et
al., 1992, 1989; Jones and Munger, 1997) causing persistent activation
of E2F transcription factors. This results in aberrant S-phase entry. Intal, The Channing Laboratories,
SA. Fax: +1 617 525 4283.
Münger).
ll rights reserved.addition, the HPV E7 oncoprotein can dysregulate apoptosis, abrogate
cell cycle arrest in response to DNA damage, differentiation or
cytostatic cytokines and cause genomic instability through induction
of centrosome duplication errors and other mechanisms (reviewed in
McLaughlin-Drubin and Munger, 2009). High-risk HPV E6 proteins in
complex with E6-associated protein (E6AP) target the p53 tumor
suppressor protein for degradation (Scheffner et al., 1990). In addition,
p53-independent activities of E6 such as telomerase activation
(Klingelhutz et al., 1996), association with PDZ proteins (Kiyono et
al.,1997; Lee et al.,1997) and other cellular target proteins (reviewed in
Howie et al., 2009) also contribute to the oncogenic activities of high-
risk HPV E6 proteins.
Epithelial cells, the targets of HPV infection, are connected by
specialized membrane structures, such as adherens junctions, tight
junctions and desmosomes, that are characterized by a localized
distribution of adhesion molecules including cadherins, catenins and
integrins. Thus, epithelial cells build a lateral layered belt by
maintaining intimate contact with neighboring cells. In contrast,
mesenchymal cells are spindle-shaped, anchorage-independent,
motile cells that neither form tightly connected nor polarized
structures. Epithelial cells can convert into mesenchymal cells by a
multi-step process known as epithelial to mesenchymal transition
(EMT). Cells undergoing EMT lose their typical epithelial character-
istics and acquire mesenchymal properties. This process is reversible
and MET denotes the process whereby mesenchymal cells reacquire
epithelial characteristics. EMT importantly contributes to several
physiological and pathological processes, including embryogenesis,
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integral to the degradation of the basal membrane, this process is
also involved in the intravasation of cells into blood or lymphatic
vessels in order to form micrometastases. Therefore, it has been
postulated that EMT is necessary for tumor dedifferentiation, a step
that is generally associated with high invasion potential and
chemoresistance (reviewed in Thiery and Sleeman, 2006).
The onset of EMT as well as the spectrum of changes that
subsequently occur, are triggered by extensive crosstalk between
signaling pathways and have two common endpoints: (1) down-
regulation of E-cadherin (Hirohashi and Kanai, 2003) and (2)
expression of EMT-associated genes. E-cadherin is a calcium-depen-
dent integral membrane glycoprotein that connects via undercoating
proteins such as catenins to actin ﬁlaments. E-cadherin can function as
a tumor suppressor bymediating invasion-suppressing properties and
maintaining the epithelial phenotype. While E-cadherin expression is
detected in well-differentiated carcinomas, expression is reduced in
many undifferentiated tumors (Hirohashi and Kanai, 2003). A
characteristic of EMT is a “cadherin switch” from expression of E-
cadherin to N-cadherin. N-cadherin is a pro-migratory protein with
expression restricted to neural tissues as well as ﬁbroblasts, osteo-
blasts, endothelial, retinal and mesothelial cells. It is typically not
expressed in epithelial cells but is detected in certain carcinomas
(Derycke and Bracke, 2004) where it is thought to promote angiogen-
esis and adhesion (reviewed in Jeanes et al., 2008). Another hallmark
of EMT is the increased expression of intermediate ﬁlament proteins
such as vimentin and ﬁbronectin. Vimentin is involved in anchoring
organelles in the cytoplasm and is often expressed in growth factor
stimulated epithelial cells. In cancers, vimentin expression is asso-
ciated with a dedifferentiated, malignant phenotype, increased
motility, invasive ability and poor clinical prognosis (reviewed in
Kokkinos et al., 2007). Fibronectin is a key component of extracellular
matrix and acts as a binding platform for cell surface receptors;
adhesion of cancer cells to ﬁbronectin enhances their tumorigenicity
and apoptosis resistance (Han and Roman, 2006).
Previous studies have suggested that high-risk HPV oncoproteins
may contribute to EMT. For example, HPV16 E6/E7 immortalizedFig.1.Differential expression of EMT-associated genes in HPV16 E6 and HPV16 E7 expressing
passage and donor matched populations. Heatmap representation of the mean-standardi
expressed in HPV16 E6 expressing versus control (E6) and HPV16 E7 versus the control (E7) p
to identify genes with similar expression patterns in HPV16 E6 and E7 expressing cells. Genes
N-cadherin; FN1, ﬁbronectin; VIM, vimentin; ACTA2, smooth muscle actin; S100A4, S100 cal
growth factor receptor 2; SNAI1, snail homolog 1; TWSG1, twisted gastrulation homolog
E-cadherin; EPPK1, epiplakin; KRT, keratin; TGFBR, transforming growth factor beta receptor.
The columns in the bar graph represent the fold change of gene expression for vimentin (
relative to control vector transfected cells.human gingival keratinocytes display a ﬁbroblast-like phenotype after
ethanol treatment (Chamulitrat et al., 2003). HPV18 E6 expressionwas
correlated with a ﬁbroblastoid morphology in SV40-immortalized
human keratinocytes (Watson et al., 2003). In addition, a microarray
analysis indicated modulation of a signiﬁcant number of genes
involved in keratinocyte differentiation and EMT by HPV16 E6 (Duffy
et al., 2003). Here we report that the HPV16 E6 and E7 oncoproteins
can each independently contribute to induction of EMT-associated
molecular changes. Since most of these observed alterations are not
apparent at the mRNA level, non-transcriptional mechanisms likely
contribute to HPV16 E6 and/or E7 induced EMT as well.
Results
HPV16 E6 and E7 modulate expression of genes involved in EMT and
differentiation-associated processes in human foreskin keratinocytes
Whereas HPV16 E6 expression in epithelial cells has previously
been shown to upregulate several genes that are normally expressed
in mesenchymal lineages (Duffy et al., 2003), the role of HPV16 E7 in
modulating the expression of EMT-related genes has not been
extensively studied. To address this issue in more detail, we analyzed
mRNA microarray expression data obtained from HFK populations
with stable expression of HPV16 E6 or E7 compared to donor and
passage matched vector control cells. We focused on a selection of 26
genes representing epithelial and mesenchymal proteins and regula-
tors involved in EMT-associated processes or differentiation. Genes
exhibiting similar patterns of expression changes in HPV16 E6 versus
HPV16 E7 expressing HFKs, each compared to control HFKs, were
identiﬁed and grouped using a hierarchical clustering algorithm. This
analysis suggested only subtle changes in the expression levels of
these genes in E6 or E7 expressing cells (Fig. 1A). This was surprising
and we validated expression of a small subgroup of these genes by
quantitative reverse transcription PCR (Fig. 1B). Collectively these
analyses revealed that whereas HPV16 E6 and E7 expression each
induce subtle alterations in gene expression levels of EMT-associated
genes, E6 or E7 expression does not cause a dramatic alteration ofcells. (A) GeneChip array analysis was performedwithmRNA isolated from two different
zed log2 expression ratios of 26 EMT and keratinocyte differentiation speciﬁc genes
opulations. Agglomerative hierarchical clustering based on Euclidean distance was used
are designated by ofﬁcial gene symbols: CTNNA2,α-catenin; CTNNBL1, β-catenin; CDH2,
cium binding protein/ﬁbroblast-surface-protein-1; AGC1, aggrecan 1; FGFR2, ﬁbroblast
1; ITGAV, vitronectin; DSP, desmoplakin; OCLN, occludin; CLDN14, claudin 14; CDH1,
(B) Quantitative reverse transcription PCR analysis for a subset of EMT marker proteins.
VIM), E-cad (CDH1), N-cad (CDH2), ﬁbronectin (FN), twist (TWSG1) and snail (SNAI1)
Fig. 2. Expression of EMT-associated proteins in HPV oncogene expressing human keratinocytes. (A) Western blot analysis of E-cadherin (E-Cad) expression in HPV16 E6 and/or E7
expressing primary human keratinocytes (HFK) as compared tomatched control HFKs. A tubulin blot is shown as a loading control. Quantiﬁcation of E-cadherin levels normalized to
tubulin expression is shown underneath. (B) Western blot analysis of ﬁbronectin (FN), vimentin (Vim), and N-cadherin (N-Cad) expression in HPV16 E6 and/or E7 and early region
(ER) expressing primary human keratinocytes (HFK) as compared to matched control HFKs. Primary human foreskin ﬁbroblasts (HFF), HPV16 positive CaSki cervical carcinoma cells
and HPV16 E7 expressing U2OS human osteosarcoma cells (U2OS/E7) were used as controls. An E7 blot documents HPV16 E7 expression in the appropriate cell populations;
expression of p53 (destabilized by E6 and stabilized by E7) is shown as a surrogate marker for HPV16 oncogene expression. A β-actin blot is shown as a loading control. (C) Western
blot analysis of ﬁbronectin (FN) and E-cadherin (E-Cad) expression in hTert immortalized normal human oral epithelial cells (NOK) and a matched population with HPV16 E7
expression (NOKE7). Primary human foreskin ﬁbroblasts (HFF) are shown as a control. An E7 blot documents HPV16 E7 expression in NOKE7, and β-actin expression is shown as a
loading control.
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ﬁbronectin, ﬁbroblast-surface-protein-1 (FSP-1, S100A4) and smooth
muscle actin. In some cases where mRNA levels changed, HPV16 E6
and E7 expression appeared to have opposing effects; expression of
TGF-β receptor II mRNA is upregulated by HPV16 E7 and down-
regulated by HPV16 E6, whereas TGF-β receptor III mRNA is down-
regulated by HPV16 E7 and upregulated by HPV16 E6. Based on these
ﬁndings we wanted to determine how expression of some of these
EMT-associated genes is modulated at the level of protein expression
and when HPV16 E6 and E7 are co-expressed.
HPV16 E7 is a modulator of EMT-associated proteins in normal human
epithelial cells
EMT is often manifested by morphological alterations whereby
epithelial cells acquire a ﬁbroblastoid phenotype. To be able to directly
compare these alterations to our mRNA analysis we analyzed E-
cadherin levels in a set of passage and donor matched populations of
HFKs with stable expression of HPV16 E6 and/or E7 by Western blot
analyses. Control vector transfected HFKs were used as controls. E-
cadherinwas expressed in HFKs and expression of HPV16 E6 or HPV16
E7 each resulted in reduced E-cadherin expression, and E-cadherinFig. 3. N-cadherin and ﬁlamentous actin expression in HPV16 E6 and/or E7 and early region
in a panel of passage and donor matched human foreskin keratinocyte (HFK) populations ex
(ER), or transfected with empty vector (C) was assessed by immunoﬂuorescence microscopy
ﬁbroblasts (HFFs) with N-cadherin siRNA (N-Cad si) or scrambled control siRNA (Ctrl si) follo
(lower panels) was visualized by ﬂuorescence microscopy of cells stained with rhodamine-expression was even more dramatically reduced in HPV16 E6/E7
expressing HFKs (Fig. 2A). The magnitude of these effects was quite
surprising given the much more subtle changes in mRNA levels in
HPV16 E7 expressing HFKs.
Based on these results we also compared expression of the
mesenchymal marker proteins ﬁbronectin and vimentin as well as
N-cadherin in HPV16 oncoprotein expressing HFKs. As expected,
expression of these proteins was very low in control vector transfected
HFKs, but they were robustly expressed in HFFs. HPV16 E6 expressing
cells only showed a subtle increase in ﬁbronectin and vimentin
expression, but expression of these proteinswasmarkedly increased in
the HPV16 E7 expressing cells. While the levels were somewhat lower
in HPV16 E6/E7 expressing HFKs or HFKs transfected with the entire
early region of HPV16, they remained higher than in control HFKs or
HFKs with expression of HPV16 E6 only. N-cadherin was not
consistently expressed at readily detectable levels in any of the HFK
populations (Fig. 2B). It is worth noting that these alterations in EMT
protein expression are not accompanied by similar changes in the
abundance of the corresponding mRNAs (Fig. 1). Moreover, HPV16 E7
expression in these cells is considerably lower than in the HPV16
positive CaSki cervical carcinoma cell line and hence the observed
effects are not a consequence of high-level HPV oncoprotein expres-(ER) expressing primary human keratinocytes (HFKs). N-Cad expression (upper panels)
pressing HPV16 E6 and/or E7 oncoproteins or the HPV16 entire early transcription unit
. The speciﬁcity of the antibody was assessed by transfection of primary human foreskin
wed by immunoﬂuorescence analysis at 48 h after siRNA transfection. Filamentous actin
conjugated phalloidin.
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vimentin as well as N-cadherin, suggesting that they show some
evidence of EMT.
To validate that HPV16 E7 expression causes alterations in levels of
EMT-associated proteins, we analyzed expression of ﬁbronectin and E-
cadherin in a matched set of hTERT immortalized normal oral
keratinocytes (NOK) and NOKs with stable expression of HPV16 E7
(NOKE7) (Piboonniyom et al., 2003). Primary human foreskin
ﬁbroblasts (HFFs) were used as controls. As expected, NOKs contained
high levels of E-cadherin and barely detectable levels of ﬁbronectin,
whereas HFFs expressed no detectable E-cadherin but had high levels
of ﬁbronectin. NOK-E7 cells contained markedly decreased levels of E-
cadherin and increased levels of ﬁbronectin (Fig. 2C).
HPV16 oncogenes E6 and E7 induce the de-novo expression of
N-cadherin in primary epithelial cells
Since N-cadherin was expressed in the HFK populations at levels
below the limit of clear detection by Western blotting (data not
shown) we performed immunoﬂuorescence experiments with these
cell populations. As expected, N-cadherin was detected at extremely
low levels in HFKs but was expressed at high levels in HFFs. HPV16 E6
as well as HPV16 E7 expressing keratinocytes also showed evidence
for increased levels of N-cadherin, which was also observed in HFKs
expressing HPV16 E6 and E7 or the entire early region (Fig. 3; upper
panels). To ascertain that the signal that we observe in these
immunoﬂuorescence experiments reﬂects N-cadherin expression,
we transfected HFFs, which express high levels of N-cadherin, with
an N-cadherin speciﬁc siRNA oligonucleotide pool or a scrambled
control siRNA as a control. N-cadherin depletion caused a dramatic
decrease in the immunoﬂuorescence signal, consistent with the
notion that we detect N-cadherin expression with this antibody.
We also stained these cells with phalloidin and detected an
increased appearance of ﬁlamentous actin that paralleled the increase
in N-cadherin expression in HPV16 oncoprotein expressing cells (Fig.
3; lower panels).
Discussion
EMT is an essential process of transdifferentiation that establishes
cell lineage identity during embryogenesis. EMT-related processes are
also triggered during carcinogenic progression. Cancer-associated
EMT, however, does not generally involve a complete lineage switch
but endows emerging tumor cells with migratory and invasive pro-
perties (reviewed in Thiery and Sleeman, 2006) and may also
contribute to the cancer-stem cell phenotype (Mani et al., 2008).
Hence, tumor-associated EMT is key to acquisition of an invasive and
metastatic phenotype and therefore to malignant progression.
Importantly, however, tumor-associated EMT is reversible through a
process that is referred to as mesenchymal to epithelial transition
(MET) (reviewed in Thiery and Sleeman, 2006). This may account for
some of the inconsistencies in studies with clinical materials that have
focused on determining tumor grade speciﬁc expression of certain
EMT markers.
EMT has been detected in cervical carcinomas (Hagemann et al.,
2007) and was correlated to EGF receptor overexpression and
increased expression and nuclear localization of the transcription
factor snail (Lee et al., 2008). HPV oncoproteins may directly
contribute to EMT induction (Duffy et al., 2003) and expression of
the HPV18 E6 oncoprotein in SV40 immortalized keratinocytes caused
morphological conversion to a ﬁbroblastoid morphology (Watson et
al., 2003). In this study we did not detect dramatic morphological
alterations in HPV16 E6 and/or E7 expressing primary human foreskin
keratinocytes and there were only subtle differences (less than 2 fold)
in mRNA levels of EMT and differentiation-associated genes in the
different cell populations. The mRNA levels of many EMT genes,including the two transcription factors and EMT master regulators,
twist and snail, were virtually unaltered. This is in contrast to a
previous study (Duffy et al., 2003), which may reﬂect the different
culture conditions that were used in the two studies. We were thus
surprised to detectmuchmore dramatic changes at the level of protein
expression. The HPV16 E7 oncoprotein importantly contributed to
induction of these changes; HPV16 E7 expressing cells displayed
markedly decreased levels of E-cadherin and increased levels of
ﬁbronectin as well as vimentin (Fig. 2).
Vimentin expression has previously been associated with acquisi-
tion of invasive properties in HPV33 transformed keratinocytes (Gilles
et al., 1994a, 1994b). In studies with clinical specimens, vimentin
expression was detected in invasive cervical carcinoma but not in
high-grade cervical intraepithelial neoplasias (CIN III) (Gilles et al.,
1996). Another study revealed vimentin expression in ∼60% of a total
of 120 cervical carcinoma specimens that were analyzed (Schaafsma
et al., 1993). Vimentin staining was extensive and throughout large
portions of the tumor in some samples, whereas in others staining
was conﬁned to small clusters of basal and parabasal cells at or near
the tumor–stromal interface. This suggests that vimentin expression
may be particularly high at the “invasive front” of the tumor.
Fibronectin staining has also been documented in some cervical
carcinomas, but staining was diffuse and not conﬁned to the invasive
front. Moreover, there was no correlation of ﬁbronectin staining with
tumor grade (Goldberg et al., 1998). HPV16 E7 has been reported to
repress the ﬁbronectin promoter (Rey et al., 2000), but we observed a
slight increase in ﬁbronectin mRNA expression (Fig. 1) and drama-
tically increased ﬁbronectin protein levels in HPV16 E7 expressing
cells (Fig. 2).
Cancer-associated EMT generally involves a cadherin switch;
whereas there is decreased E-cadherin expression, N-cadherin is
expressed at higher levels. Loss of E-cadherin expression has been
reported in many tumors. In some tumor types, including cervical
carcinomas, E-cadherin may be transcriptionally silenced by DNA
hypermethylation (Chen et al., 2003; Dong et al., 2001; Kang et al.,
2005; Narayan et al., 2003; Shivapurkar et al., 2007; Terra et al., 2007;
Yang et al., 2006). While the mechanism of the decreased E-cadherin
expression inHPV oncoprotein expressingHFKs is not clear, our results
are consistentwith a recent report that depletion ofHPV16 E7 by siRNA
in HPV16 transformed human keratinocytes restored normal E-
cadherin expression through a mechanism that is likely independent
of the transcription factors slug and snail (Caberg et al., 2008).
Furthermore, expression of the HPV16 E7 related SV40 large tumor
antigen in MDCK cells induced EMTand loss of E-cadherin and keratin
expression (Martel et al., 1997). Moreover, siRNA mediated depletion
of pRB, which is targeted for degradation by HPV16 E7, resulted in
deregulated E-cadherin expression, reduced cell-to-cell adhesion and
EMT-related morphological alterations in MCF7 breast cancer cells.
Most strikingly, there was concurrent down-regulation of pRB and E-
cadherin expression in mesenchymal-like invasive breast cancer
specimens (Arima et al., 2008). It will be interesting to determine
whether the ability of HPV16 E7 to reduce E-cadherin expression is
linked to the ability to destabilize pRB.
N-cadherin expression is linked to increased cell motility and
invasiveness in tumors (Derycke and Bracke, 2004) and ectopic N-
cadherin expression in epithelial cells causes morphological altera-
tions and increased motility (Hazan et al., 1997; Islam et al., 1996). In
our experiments N-cadherin mRNA levels were unaltered in HPV16
oncogene expressing cells and the protein levels remained below the
level of consistent, reliable detection by Western blotting in multiple
HFK populations that we tested. However, we consistently observed
increased N-cadherin levels in HPV16 E6 and/or E7 expressing HFKs
as compared to control cells by immunoﬂuorescence (Fig. 3).
In summary, our data suggest thatHPV16 E7 importantly contributes
to inductionof anEMT-relatedprocess in epithelial cells. Consistentwith
this notion, previous studies with transgenic mice showed that HPV16
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sufﬁcient for induction of invasive cervical carcinomas (Riley et al.,
2003), which conceivably involves EMT. While co-expression of the
HPV16 E6 oncogene resulted in the formation of larger, more extensive
carcinomas, HPV16 E6 expressing mice only developed precancerous
lesions (Riley et al., 2003). Since the observed changes in E-cadherin,
ﬁbronectin and vimentin expression in HPV16 E7 expressing HFKswere
much more dramatic than what would have been predicted from our
mRNA expression analysis, we hypothesize that HPV16 E7 may affect
EMT, at least in part through non-transcriptional mechanisms. Indeed,
HPV16 E7 causes stabilization of the p53 tumor suppressor and the cdk
inhibitor p21CIP1 (Jones andMunger,1997; Jones et al.,1999) and targets
the tumor suppressor pRB and the related p107 and p130 proteins for
degradation (Boyer et al.,1996; Gonzalez et al., 2001; Jones andMunger,
1997; Zhang et al., 2006). Hence, it is conceivable that E7 may either
directly alter the stability of these EMT-related proteins or modulate




The following human β-actin promoter expression plasmids were
used: p1435 (HPV16 E7), p1436 (HPV16 E6), p1321 (HPV16 E6/E7),
p1319 (HPV16 early region) and the parental vector p1318 (Munger et
al., 1989).
Cell lines and culture
Primary human foreskin keratinocytes (HFK) were isolated from
anonymous neonatal circumcisions. Two to ﬁve human foreskins per
culture were washed with phosphate-buffered saline (PBS) and diced
into small fragments. After incubation in 25mg dispase/ml PBS at 4 °C
overnight, the epidermis was separated from the dermis, minced and
trypsinized into a single-cell suspension. HKFs were maintained in
keratinocyte serum free medium (KSF-M; Invitrogen) supplemented
with human recombinant epidermal growth factor 1–53, bovine
pituitary extract, 100 U/ml penicillin, 100 μg/ml streptomycin, 10 μg/
ml gentamicin, and 0.5 μg/ml amphotericin B. HFKs with stable
expression of HPV16 E6, E7, E6 and E7 or the early region (ER) were
created by transfecting primary HFK populations with the appropriate
expression plasmids and pCDNA3.1 (Invitrogen) at 5:1 ratio using the
Amaxa Human Keratinocyte Nucleofector kit (Amaxa Biosystems)
according to the manufacturer's instructions. Following selectionwith
G418, the cells were cultured in the KSF-M. Normal oral keratinocytes
(NOK) immortalized by human telomerase (hTERT) and NOK hTERT/
E7 (Piboonniyom et al., 2003) were maintained in KSF-M.
Primary human foreskin ﬁbroblasts (HFFs) were generated from
anonymous newborn circumcisions. Dermis that was separated from
the epidermis during keratinocyte preparation was minced and
incubated in a 2 mg/ml collagenase solution in serum free DMEM
and trypsin (4:1) for 4 h at 37 °C. HFFs were maintained in DMEM
supplemented with 10% calf serum, 50 U/ml penicillin, and 50 μg/ml
streptomycin.
HPV16-positive CaSki human cervical carcinoma were obtained
fromATCC and cultured inDulbecco'smodiﬁed Eaglemedium(DMEM,
Invitrogen), 10% fetal bovine serum, and 1% penicillin/streptomycin.
Immunoblotting
Cells were extracted in RIPA buffer (150mMNaCl, 1% Nonidet P-40,
0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 50 mM Tris–
HCl pH 8.0) supplemented with one complete EDTA-free protease
inhibitor cocktail tablet (Roche) per 25 ml lysis buffer. Cells were
scraped on ice and lysates were cleared by centrifugation at 16,000 ×gfor 15 min at 4 °C. Protein concentrations were measured using the
Bradford method (Bio-Rad). Samples containing 50 to 200 μg of
protein were boiled in SDS-containing sample buffer, separated by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
onto polyvinylidene diﬂuoride membranes (Millipore). Membranes
were blocked for 1 h in 5% nonfat dry milk and 1% BSA in TNET buffer
(50 mM Tris–HCl, 150 mM NaCl, 5 mM EDTA, 0.1% Tween-20) or TBST
buffer (10 mM Tris–HCl, 150 mM NaCl, 0.1% Tween-20) and probed
with the appropriate antibody. Primary antibodies were used at the
following dilutions: a mixture of 8C9 (1:150; Zymed/Invitrogen) and
ED17 (1:200; Santa Cruz) for HPV16 E7, ﬁbronectin (sc-59826, 1:50;
Santa Cruz), vimentin (V9, 1:1,000; Chemicon), N-cadherin (610920,
1:2,500; BD), E-cadherin (610181, 1:250; BD), p53 (OP43, 1:1,000;
Oncogene Science), pRB (sc-7905, 1:500; Santa Cruz), β-actin (CP01,
1:1,000; Calbiochem) and α-tubulin (T6199, 1:1,000; Sigma). Appro-
priate secondary anti-mouse horseradish peroxidase-conjugated
antibodies were used (1:10,000; Amersham). Proteinswere visualized
by enhanced chemiluminescence (Western Lightning Chemilumines-
cence Reagent Plus, Perkin-Elmer Life Science, Inc.) and exposed on
BioMax XAR ﬁlm (Kodak) or electronically acquired with a 4000R
image station (Kodak). Band quantiﬁcation analysis was performed
using the Kodak imaging software, version 4.0.
Immunoﬂuorescence
Cells were plated on glass coverslips, ﬁxed with 3% paraformalde-
hyde in phosphate-buffered saline (PBS), washed with PBS, and
permeabilized with 1% Triton X-100 in PBS for 10 min at room
temperature. Following permeabilization the cells were washed with
wash buffer (PBS containing 0.02% saponin, 0.05% sodium azide, and
1% bovine serum albumin (BSA)), blocked with 10% normal goat
serum (Jackson Immunoresearch) at room temperature for an hour
and incubated for 45 min with N-cadherin antibody (610920, BD) at
37 °C. Blocking solution and antibodies were diluted in wash buffer.
Secondary antibody was an Alexa Fluor 488-conjugated goat anti-
mouse antibody (1:1,000; Invitrogen). Nuclei were counterstained
with Hoechst 33258 (Sigma) and TO-PRO-3 (Invitrogen) dyes at a
1:2000 dilution. Phalloidin staining was performed using a 1:100
dilution of rhodamine-conjugated phalloidin (Molecular Probes/
Invitrogen) followed by counterstaining with Hoechst and TO-PRO-3.
siRNA experiments
HFFs were grown on coverslips for 24 h until they were
approximately 40% conﬂuent, followed by transfection with N-
cadherin speciﬁc siRNA oligonucleotides (“SMARTpool”, Millipore)
or a scrambled control siRNA (Millipore) using Lipofectamine2000
(Invitrogen). After incubation for 48 h the cells were ﬁxed and stained
as described above.
Microarray analysis
Messenger RNA was isolated with the Agilent RNA Isolation kit
accordingly to the manufacturer's protocol from four independent,
passage and donor matched HFK populations with stable expression
of HPV16 E6 or E7 and control vector transfected primary HFKs. RNA
quality was evaluated using the Agilent BioAnalyzer 2100 and gene
expression proﬁles were assayed using the Affymetrix U133Plus2.0
GeneChip™ according to the manufacturer's instructions. Data were
normalized using RMA and array quality assessed using NUSE and RLE
scores (Irizarry et al., 2003); a variety of statistical and data mining
analyses were performed to identify genes and patterns of gene
expression correlating with the various phenotypes. Log2 ratios of
gene expression in HPV16 E6 versus the vector control cells, and
HPV16 E7 expressing versus the empty vector control cells were
calculated and mean-centered and subjected to average-linkage
62 K. Hellner et al. / Virology 391 (2009) 57–63hierarchical clustering using a Euclidean distance metric (Eisen et al.,
1998; Michaels et al., 1998; Wen et al., 1998) using the heatmap2
function in the gplots package (http://cran.r-project.org/web/
packages/gplots/index.html) implemented in the open source statis-
tical computing language R (http://www.r-project.org/). All gene
expression data were collected in accordance with the MIAME
standards (Brazma et al., 2001) and have been deposited with the
ArrayExpress database under accession number E-MTAB-114.
Real-time PCR
Quantitative real time PCR was performed using the QuantiTect
SYBRGreen PCR kit (Qiagen) following the manufacturer's instruc-
tions. Samples were analyzed on a 7300 Fast RT-PCR system (Applied
BioSystems) in triplicate together with the matching negative
controls. Primers were: SNAI1 forward ATG AGG AAT CTG GCT GCT
GT and reverse CAG GAG AAA ATG CCT TTG GA; TWIST1 forward TGC
ATG CAT TCT CAA GAG GT and reverse CTA TGG TTT TGC AGG CCA GT;
FN1 forward GGA GTT GAT TAT ACC ATC ACT G and reverse TTT CTG
TTT GAT CTG GAC CT; CDH2 forward TGG GAA TCC GAC GAA TGG and
reverse TGC AGA TCG GAC CGG ATA CT; CDH1 forward TGA AGG TGA
CAGAGC CTC TGGATand reverse TGG GTGAAT TCG GGC TTG TT; GAP-
DH forward GAT TCC ACC CAT GGC AAA TTC and reverse TGG GAT TTC
CAT TGA TGA CAA G; VIM forward CCA AAC TTT TCC TCC CTG AAC C
and reverse GTG ATG CTG AGA AGT TTC GTT GA.
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